Myeloid Therapeutics Funding: $195M Raised, Series A (2026)

Myeloid Therapeutics is based in Cambridge, MA. It has raised $195M in total funding. Latest round: Series A.

Myeloid Therapeutics funding overview

Myeloid Therapeutics is based in Cambridge, MA. Myeloid Therapeutics has raised $195M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in May 2026. The round record for Myeloid Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Newpath Partners, ARCH Venture Partners, Hatteras Venture Partners, Moore Strategic Ventures, 8VC, Alexandria Venture Investments. 6 distinct backers are named across the disclosed rounds.

Myeloid Therapeutics at a glance

Total raised
$195M
Latest round
Series A
Latest round date
May 2026
Headquarters
Cambridge, MA
Notable investors
Newpath Partners, ARCH Venture Partners, Hatteras Venture Partners, Moore Strategic Ventures, 8VC, Alexandria Venture Investments

Frequently asked about Myeloid Therapeutics funding

How much has Myeloid Therapeutics raised?
Myeloid Therapeutics has raised $195M in total disclosed funding across the rounds on record.
Who has invested in Myeloid Therapeutics?
Newpath Partners, ARCH Venture Partners, Hatteras Venture Partners, Moore Strategic Ventures, 8VC, Alexandria Venture Investments are named among the investors backing Myeloid Therapeutics.
What was the latest Myeloid Therapeutics funding round?
The most recent disclosed round is a Series A, announced in May 2026.
Where is Myeloid Therapeutics based?
Myeloid Therapeutics is based in Cambridge, MA.
When did Myeloid Therapeutics last raise?
The last disclosed Myeloid Therapeutics round closed in May 2026 at Series A.

Every Myeloid Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.

Companies related to Myeloid Therapeutics (25)

Browse related funding lists (9)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades